Should antibody agents be approved against severe Covid-19 course?- This News is powered Google News, thanks

Saturn-nazi

No antibody agent against Covid-19 has yet been approved, and the Regeneron agent is also unlikely to be available for ordinary patients for a long time. Another disadvantage of the antibody agents is the high production costs. Experts nevertheless hope that these could be approved as a vaccine sooner – and as a kind of bridging technology, help to reduce the risk of disease. A problem with severe Covid-19 courses is apparently an often too late, but then excessively strong reaction of the immune system. Antibody preparations could attack the virus in the early phase of the infection and thus alleviate the course of the disease.

So is Trump a prominent evidence of a possible miracle drug against Sars-CoV-2? US epidemiologist Fauci emphasizes that in the case of the US president it was really the antibodies that made him fit again quickly in the end. A number of studies would first have to be carried out for this. And Trump’s illness is not over yet. “He looks good,” said Fauci of the US president’s appearance after his dismissal. But the epidemiologist also warns that Covid-19 has repeatedly proven to be treacherous in the past – sometimes there could still be “a reversal after five to eight days” with a serious deterioration in the condition. Although that is not likely. “But you should be prepared for it.”

(Visited 1 times, 1 visits today)

Tags: suchen suche search tag anzeigen besucherzahl browser design domain inhalt jahr karpfen konto problem inhalt schalten modellbahn spielemax spiel tag webseite preise werbung

Reichsmarschall Göring hatte eine Märklin Modelleisenbahn >>> read more



Schreibe einen Kommentar


ID for Download Paper 28468